Compounds with antitumor activity identified in a new variety of eggplant

by Instituto de Investigación Biosanitaria - Ibs Granada

5 months ago
S0506, eggplant, colon cancer, flavonoids and polyphenols, kaempferol, quercetin, and protodiosin

A study developed by the UGR and ibs.GRANADA, with the collaboration of the Cellbitec Foundation, demonstrates the effectiveness of eggplant seed extracts S0506 against colon cancer, both in the labor...

CNIO researchers discover a molecular mechanism that initiates colon cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

1 year ago
colon cancer, p53 protein, URI, MYC

A study led by CNIO researcher Nabil Djouder finds that the shortage of the p53 protein in animal models triggers colorectal tumours

Flomics Investment opportunity

by Flomics Biotech SL

6 years ago
investment, genomics, Flomics, liquid biopsy, colon cancer, lung

Flomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) operating in the genomics and liquid biopsy fields is excited to announce the launch of its seed investment round of 500.0...

A pilot study of the sequencing of the intestinal microbiota establishes the basis for the search of early detection markers of colon cancer

by Hospital Universitari de Bellvitge

6 years ago
intestinal microbiota, makers, early detection, colon cancer

In this pilot study, they used colon biopsies samples and feces samples from nine patients to compare two sequencing methods. It has been defined the appropriate bioinformatic analysis methods for thi...

Ramon Salazar receives funding for a research project on colon cancer

by IBEC - Institut de Bioenginyeria de Catalunya

9 years ago
colon cancer, TRASCAN, circulating DNA

His research work on colon cancer focuses on studying the circulating DNA in the tumor to identify the risk of persistent disease in stages 2 and 3. This project is carried out in collaboration with E...

A new genetic marker accounts for up to 1.4% of cases of hereditary colon cancer

by IBEC - Institut de Bioenginyeria de Catalunya

9 years ago
colon cancer, genetic marker

Researchers from the Hereditary Cancer group of the Oncobell Program of the Bellvitge Biomedical Research Institute (IDIBELL) - Hereditary Cancer Program of the Catalan Institute of Oncology (ICO) hav...

Olive skin as inhibitor of intestinal tumors

by Universitat de Barcelona

9 years ago
food supplements, familial adenomatous polyposis, colon cancer, Biomaslínic

The good results regarding the inhibition of cell cycle in different tumor lines made place for the valorization of a new project which could be very interesting for food supplements on patients affec...

A new genetic test improves and expands the detection of mutations that cause resistance to colon cancer treatments

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

10 years ago
Biocartis, genetic test, colon cancer, anti-EGFR therapy

The expansion of the genetic test allows the detection of newly identified mutations by a team of oncologists at Hospital del Mar and the IMIM.

Liquid biopsy identifies mutations in colorectal cancer that go undetected in tissue biopsy

by Vall d’Hebron

11 years ago
BEAMing, Colorectal cancer, colon cancer, CORRECT study, Liquid biopsy

The CORRECT study, published ahead of print online today in The Lancet Oncology, is one of the largest trials to date comparing data provided by liquid versus tissue biopsy in metastatic colorectal ca...

Hospital del Mar: identifican cinco nuevas mutaciones genéticas del cáncer de colon que predicen si habrá resistencia el tratamiento quimioterápico más habitual

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

11 years ago
colon cancer, biopsia líquida, colorectal cancer, EFGR gene

Las seis mutaciones identificadas por los oncólogos del Hospital del Mar sobre el gen EFGR, publicadas en la revista Clinical Cancer Research, tienen mecanismos de resistencia al fármaco cetuximab

Antitumor agent improves survival of patients with treatment-resistant metastatic colorectal cancer

by Vall d’Hebron

11 years ago
Colorectal Cancer, colon cancer, TAS-102

The results of this trial, although modest in terms of benefit, are important since they offer these patients an alternative therapy against the advancement of their disease – whereas previously no ...

Discovery of the genetic fingerprint of aggressive colon tumours

by IRB Barcelona - Instituto de Investigación Biomédica

11 years ago
colon cancer

A study published in Nature Genetics by researchers at IRB Barcelona explains the basis for the classification of colon tumours in good or bad prognosis by analysing the tissue surrounding the tumour ...